China's Leading Vaccine Developer Sinovac Sees Earnings Sink Into The Red As Scandals Rock Public Confidence
This article was originally published in PharmAsia News
Executive Summary
BEIJING - A series of vaccine scandals across China, and resulting public fear over all forms of inoculations, has caused the country's leading vaccine developer, Sinovac Biotech, to post a loss for the third quarter of this year